🕵️ Shoulder Innovations, Inc. ($SI)
SEC insider & ownership activity, last 12 months · CIK 1699350 · every row links its SEC filing
Over the last 12 months insiders sold $374K against $12.0M of open-market buying. LSV Associates II, LLC bought $4.0M in discretionary trades (Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
8 buyers, $12.0M (17 lots) · 1 seller, $374K (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| LSV Associates II, LLC | 1 | $4.0M | 0 | – | Aug 1, 2025 |
| Michael A Carusi | 1 | $4.0M | 0 | – | Aug 1, 2025 |
| Gilde Healthcare Holding B.v. | 1 | $1.5M | 0 | – | Aug 1, 2025 |
| Geoffrey B. Pardo | 1 | $1.5M | 0 | – | Aug 1, 2025 |
| Casey M. Tansey | 1 | $600K | 0 | – | Aug 1, 2025 |
| Matthew Ahearn | 0 | – | 3 | $374K | Jun 15, 2026 |
| Ball Robert Joseph | 5 | $263K | 0 | – | Mar 13, 2026 |
| Buchholz Richard | 2 | $90K | 0 | – | Mar 13, 2026 |
| Jeffrey S. Points | 5 | $85K | 0 | – | Mar 13, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 19.0% | 13G | Sep 8, 2025 | filing ↗ | |
| Abigail P. Johnson | 19.0% | 13G | Sep 8, 2025 | filing ↗ | |
| Casey M. Tansey | 13.3% | 13G | Nov 14, 2025 | filing ↗ | |
| Presidio Management Group XII, L.L.C. | 13.1% | 13G | Nov 14, 2025 | filing ↗ | |
| Gilde Healthcare V Management B.V. | 11.8% | 13D | Aug 1, 2025 | filing ↗ | |
| Cooperatieve Gilde Healthcare V U.A. | 11.8% | 13D | Aug 1, 2025 | filing ↗ | |
| Manapouri B.v. | 11.8% | 13D | Aug 1, 2025 | filing ↗ | |
| Martemanshurk B.v. | 11.8% | 13D | Aug 1, 2025 | filing ↗ | |
| Gilde Healthcare Holding B.v. | 11.8% | 13D | Aug 1, 2025 | filing ↗ | |
| LSV Associates II, LLC | 9.3% | 13G | Nov 14, 2025 | filing ↗ | |
| Michael A Carusi | 9.3% | 13G | Nov 14, 2025 | filing ↗ | |
| Jean George | 9.3% | 13G | Nov 14, 2025 | filing ↗ | |
| Henry A. Plain Jr. | 9.3% | 13G | Nov 14, 2025 | filing ↗ | |
| Lightstone Ventures II, L.P. | 8.7% | 13G | Nov 14, 2025 | filing ↗ | |
| U.S. Venture Partners XII, L.P. | 8.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Arboretum Ventures VI, L.P. | 5.8% | 13G | Aug 8, 2025 | filing ↗ | |
| Arboretum Investment Manager VI, LLC | 5.8% | 13G | Aug 8, 2025 | filing ↗ | |
| Jan L. Garfinkle | 5.8% | 13G | Aug 8, 2025 | filing ↗ | |
| Daniel M. Kidle | 5.8% | 13G | Aug 8, 2025 | filing ↗ | |
| Thomas M. Shehab | 5.8% | 13G | Aug 8, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Matthew Ahearn | $375K | Jun 12, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 26, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jun 26, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 26, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 26, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 13, 2026 | filing ↗ |
| Earnings (2.02) | Mar 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 3, 2025 | filing ↗ |
| Earnings (2.02) | Nov 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 11, 2025 | filing ↗ |
| Earnings (2.02) | Sep 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 9, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Aug 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 1, 2025 | filing ↗ |